Abstract
The safety and efficacy of a new highly purified neutral soluble human insulin produced by conversion of porcine insulin was compared with a highly purified neutral soluble porcine insulin in six normal men. The insulins were administered by subcutaneous injection at a dose of 0.075 U/kg body weight. Somatostatin was infused during the experiment to suppress endogenous insulin secretin. No difference was found in the plasma glucose, insulin, or metabolite responses. Thus the potency, onset, and duration of effect were identical with the two insulins. No short-term side effects to either insulin were observed. Highly purified, semi-synthetic human insulin offers a safe and effective means to explore the possible advantages of homologous human insulin in the management of diabetes mellitus.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberti K. G., Christensen N. J., Christensen S. E., Hansen A. P., Iversen J., Lundbaek K., Seyer-Hansen K., Orskov H. Inhibition of insulin secretion by somatostatin. Lancet. 1973 Dec 8;2(7841):1299–1301. doi: 10.1016/s0140-6736(73)92873-0. [DOI] [PubMed] [Google Scholar]
- Assan R. La somatostatine : une nouvelle hormone. Diabete Metab. 1976 Sep;2(3):135–146. [PubMed] [Google Scholar]
- Felig P., Wahren J. Somatostatin and diabetes: suppression of glucose absorption rather than stimulation of glucose disposal. Metabolism. 1976 Nov;25(11 Suppl 1):1509–1510. doi: 10.1016/s0026-0495(76)80180-1. [DOI] [PubMed] [Google Scholar]
- Foster K. J., Alberti K. G., Hinks L., Lloyd B., Postle A., Smythe P., Turnell D. C., Walton R. Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem. 1978 Sep;24(9):1568–1572. [PubMed] [Google Scholar]
- Heding L. G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia. 1972 Aug;8(4):260–266. doi: 10.1007/BF01225569. [DOI] [PubMed] [Google Scholar]
- Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
- KREINES K. THE USE OF VARIOUS INSULINS IN INSULIN ALLERGY. Arch Intern Med. 1965 Aug;116:167–171. doi: 10.1001/archinte.1965.03870020007003. [DOI] [PubMed] [Google Scholar]
- Keen H., Glynne A., Pickup J. C., Viberti G. C., Bilous R. W., Jarrett R. J., Marsden R. Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet. 1980 Aug 23;2(8191):398–401. doi: 10.1016/s0140-6736(80)90443-2. [DOI] [PubMed] [Google Scholar]
- Lloyd B., Burrin J., Smythe P., Alberti K. G. Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem. 1978 Oct;24(10):1724–1729. [PubMed] [Google Scholar]
- MIRSKY I. A., JINKS R., PERISUTTI G. THE ISOLATION AND CRYSTALLIZATION OF HUMAN INSULIN. J Clin Invest. 1963 Dec;42:1869–1872. doi: 10.1172/JCI104871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morihara K., Oka T., Tsuzuki H. Semi-synthesis of human insulin by trypsin-catalysed replacement of Ala-B30 by Thr in porcine insulin. Nature. 1979 Aug 2;280(5721):412–413. doi: 10.1038/280412a0. [DOI] [PubMed] [Google Scholar]
- NICOL D. S., SMITH L. F. Amino-acid sequence of human insulin. Nature. 1960 Aug 6;187:483–485. doi: 10.1038/187483a0. [DOI] [PubMed] [Google Scholar]
- Sieber P., Kamber B., Hartmann A., Jöhl A., Riniker B., Rittel W. Totalsynthese von Humaninsulin unter gezielter Bildung der Disulfidbindungen. Helv Chim Acta. 1974;57(8):2617–2621. doi: 10.1002/hlca.19740570839. [DOI] [PubMed] [Google Scholar]
- Teuscher A. Die biologische Wirkung von vollsynthetischem humanem Insulin bei Patienten mit Diabetes mellitus. Schweiz Med Wochenschr. 1979 May 19;109(20):743–747. [PubMed] [Google Scholar]